Rates of escalation to triple COPD therapy among incident users of LAMA and LABA/LAMA

This study aimed to characterize patients initiating treatment with the LAMA tiotropium (TIO) and the fixed-dose LAMA/LABA combination therapy umeclidinium/vilanterol (UMEC/VI), and to compare rates of escalation to TT between patients receiving these therapies.

Source: Respiratory Medicine - April 21, 2018 Category: Respiratory Medicine Authors: Beth Hahn, Michael Hull, Cori Blauer-Peterson, Ami R. Buikema, Riju Ray, Richard H. Stanford Source Type: research